Quantum-Si incorporated (QSI)
| Market Cap | 107.85M |
| Revenue (ttm) | 1.70M |
| Net Income (ttm) | -89.35M |
| Shares Out | 142.36M |
| EPS (ttm) | -0.63 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 324,797 |
| Open | 0.745 |
| Previous Close | 0.768 |
| Day's Range | 0.735 - 0.764 |
| 52-Week Range | 0.700 - 2.430 |
| Beta | 2.93 |
| Analysts | Strong Buy |
| Price Target | 4.00 (+427.98%) |
| Earnings Date | Nov 12, 2024 |
About QSI
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company’s platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications. The company was founded in 2013 is... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to one analyst, the rating for QSI stock is "Strong Buy" and the 12-month stock price forecast is $4.0.
News
Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Company will host an Investor ...
Quantum-Si to Present at the 2024 American Society of Human Genetics Annual Meeting
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced its attendance at the 2024 American Soc...
Quantum-Si to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
BRANFORD, Conn.--(BUSINESS WIRE)--QSI to report Q3 2024 Operating Results on 11/12/24.
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn.--(BUSINESS WIRE)--QSI announces inducement grants.
Renowned Proteomic Researchers to Present Quantum-Si Data at World HUPO 2024
BRANFORD, Conn.--(BUSINESS WIRE)--Renowned Proteomic Researchers to Present Quantum-Si Data at World HUPO 2024.
Northwestern Proteomics Center of Excellence Partners with Quantum-Si for Webinar on Advancing Proteoform Analysis with Top-Down Mass Spectrometry and Single-Molecule Sequencing
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si announces proteomics webinar.
Liberate Bio Integrates Quantum-Si's Next-Generation Protein Sequencing™ Platform to Enhance Gene Therapy Development
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that Liberate Bio, a Boston-based biote...
CORRECTING and REPLACING Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si announces promotions and appointment of CCO.
Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si announces promotions and appointment of CCO.
Quantum-Si to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in the 2...
Quantum-Si incorporated (QSI) Q2 2024 Earnings Call Transcript
Quantum-Si incorporated (NASDAQ:QSI) Q2 2024 Earnings Call Transcript August 7, 2024 4:30 PM ET Company Participants Doug Farrell - VP, IR Jeff Hawkins - President and CEO Jeff Keyes - CFO Conference...
Quantum-Si Reports Second Quarter 2024 Financial Results
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si reports Q2 2024 Operating Results.
Quantum-Si to Participate in the Canaccord Genuity 44th Annual Growth Conference
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to webcast presentation from the Canaccord 44th Annual Growth Conference.
Quantum-Si to Report Second Quarter 2024 Financial Results on August 7, 2024
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to report second quarter 2024 operating results on Wednesday, August 7, 2024.
Quantum-Si Announces Presentation on the Use of Next-Generation Protein Sequencing™ to Detect Disease-Relevant Proteoforms at the Festival of Genomics and Biodata
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a presentation by Gloria Sheynkman, Ph....
Quantum-Si Announces Presentations at ASMS and ESHG
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Presentations at ASMS and ESHG.
Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors.
Lab Instrument Industry Update - New Commercial Entrants
Lab Instrument and Services providers in the healthcare industry can generate high recurring revenues. Many loss-making instrument makers in the industry may not provide meaningful returns and carry h...
Quantum-Si Incorporated (QSI) Q1 2024 Earnings Call Transcript
Quantum-Si Incorporated (NASDAQ:QSI) Q1 2024 Earnings Conference Call May 9, 2024 4:30 PM ET Company Participants Katherine Atkinson - Senior Vice President-Commercial Marketing Jeff Hawkins - Presid...
Quantum-Si Reports First Quarter 2024 Financial Results
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the first quarter...
Quantum-Si Announces Upgrades to Analysis Software that will Provide Customers with Higher Data Output and Precision and Shorter Processing Time
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced upgrades to its Platinum® Analysis Soft...
Quantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024.
Quantum-Si Appoints Former Illumina and Cisco Systems Executive, Paula Dowdy, to its Board of Directors
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced the appointment of Paula Dowdy, a seni...
Quantum-Si and Researchers to Highlight the Power of Next-Generation Protein Sequencing™ on Platinum® at US HUPO Conference
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (NASDAQ: QSI): WHAT: The Protein Sequencing Company™, Quantum-Si Incorporated, will showcase its Next-Generation Protein Sequencing™ instrumen...
Quantum-Si Incorporated (QSI) Q4 2023 Earnings Call Transcript
Quantum-Si Incorporated (QSI) Q4 2023 Earnings Call Transcript